TY - JOUR
T1 - Valore prognostico dello score clinico di Morise, del calcium score e dell'angiografia coronarica mediante tomografia computerizzata in pazienti con malattia coronarica sospetta o nota
AU - Maffei, E.
AU - Seitun, S.
AU - Palumbo, A.
AU - Martini, C.
AU - Emiliano, E.
AU - Cuttone, A.
AU - Aldrovandi, A.
AU - Malagò, R.
AU - La Grutta, L.
AU - Midiri, M.
AU - Tedeschi, C.
AU - De Rosa, R.
AU - Catalano, O.
AU - Weustink, A.
AU - Mollet, N.
AU - Cademartiri, F.
PY - 2011/12
Y1 - 2011/12
N2 - Purpose: Our aim was to determine the prognostic value of computed tomography coronary angiography (CTCA), coronary artery calcium scoring (CACS) and Morise clinical score in patients with known or suspected coronary artery disease (CAD). Materials and methods: A total of 722 patients (480 men; 62.7±10.9 years) who were referred for further cardiac evaluation underwent CACS and contrast-enhanced CTCA to evaluate the presence and severity of CAD. Of these, 511 (71%) patients were without previous history of CAD. Patients were stratified according to the Morise clinical score (low, intermediate, high), to CACS (0-10, 11-100, 101-400, 401-1,000, >1,000) and to CTCA (absence of CAD, nonsignificant CAD, obstructive CAD). Patients were followed up for the occurrence of major events: cardiac death, nonfatal myocardial infarction, unstable angina and revascularisation. Results: Significant CAD (>50% luminal narrowing) was detected in 260 (36%) patients; nonsignificant CAD (1,000 were significant predictors of events (p
AB - Purpose: Our aim was to determine the prognostic value of computed tomography coronary angiography (CTCA), coronary artery calcium scoring (CACS) and Morise clinical score in patients with known or suspected coronary artery disease (CAD). Materials and methods: A total of 722 patients (480 men; 62.7±10.9 years) who were referred for further cardiac evaluation underwent CACS and contrast-enhanced CTCA to evaluate the presence and severity of CAD. Of these, 511 (71%) patients were without previous history of CAD. Patients were stratified according to the Morise clinical score (low, intermediate, high), to CACS (0-10, 11-100, 101-400, 401-1,000, >1,000) and to CTCA (absence of CAD, nonsignificant CAD, obstructive CAD). Patients were followed up for the occurrence of major events: cardiac death, nonfatal myocardial infarction, unstable angina and revascularisation. Results: Significant CAD (>50% luminal narrowing) was detected in 260 (36%) patients; nonsignificant CAD (1,000 were significant predictors of events (p
KW - Calcium score
KW - Computed tomography coronary angiography
KW - Morise score
KW - Prognosis
KW - Prognostic value
UR - http://www.scopus.com/inward/record.url?scp=83655167291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83655167291&partnerID=8YFLogxK
U2 - 10.1007/s11547-011-0721-6
DO - 10.1007/s11547-011-0721-6
M3 - Articolo
C2 - 21892713
AN - SCOPUS:83655167291
VL - 116
SP - 1188
EP - 1202
JO - Radiologia Medica
JF - Radiologia Medica
SN - 0033-8362
IS - 8
ER -